Stay updated on Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.

Latest updates to the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025, and the revision number has been updated from v2.16.2 to v2.16.4.SummaryDifference1%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check62 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check77 days agoChange DetectedThe webpage has undergone significant content changes, including the removal of detailed background information on type 2 diabetes and heart failure, while adding a new study focus on the effects of pioglitazone and dapagliflozin on hospitalization rates for heart failure in patients with preserved ejection fraction.SummaryDifference30%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin+Low-Dose Pioglitazone on HF Hospitalization Clinical Trial page.